In September 2017, CHIL initiated its first export of diagnostic solutions to Panama, opening the company’s footprint in Central America. This milestone underscored CHIL’s commitment to delivering reliable and high-quality diagnostics globally. Building on previous international achievements, the Panama launch set the stage for further regional growth and strengthened the company’s global presence.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.